Valuation: EirGenix Inc.

Market Cap 14.61B 455M 398M 367M 339M 644M 43.43B 655M 4.39B 1.72B 21.39B 1.71B 1.67B 73.55B P/E 2024
-31.6x
P/E 2025 -24.5x
Enterprise Value 12.79B 399M 349M 322M 297M 564M 38.02B 573M 3.84B 1.51B 18.73B 1.5B 1.46B 64.39B EV / Sales 2024
18.2x
EV / Sales 2025 16.8x
Free-Float
60%
Yield 2024 *
-
Yield 2025 -
1 day-2.33%
1 week-2.92%
Current month-3.31%
1 month+6.04%
3 months-8.79%
6 months-23.53%
Current year-21.80%
1 week 48.25
Extreme 48.25
53.6
1 month 44.2
Extreme 44.2
53.6
Current year 40.15
Extreme 40.15
67.6
1 year 40.15
Extreme 40.15
84.3
3 years 40.15
Extreme 40.15
112
5 years 40.15
Extreme 40.15
163.5
10 years 21.55
Extreme 21.55
195
Manager TitleAgeSince
Chief Executive Officer - 01/04/2013
Director of Finance/CFO - 03/05/2016
Corporate Officer/Principal - 20/05/2019
Director TitleAgeSince
Director/Board Member - 14/06/2013
Director/Board Member - 13/09/2016
Director/Board Member - 13/09/2016
Change 5-day change 1-year change 3-year change Capi.($)
-2.33%-2.92%-22.05%-55.32% 455M
-0.51%+1.57%+18.72%-5.52% 67.61B
-5.16%-8.63%+37.37%+202.27% 51.6B
+5.28%+39.50%+39.50%+39.50% 43B
-2.10%+0.89%-49.30%-53.47% 40.94B
+0.12%-7.85%+47.16%-29.27% 29.4B
-10.83%-14.41%+99.15%-44.54% 27.09B
-1.53%-0.13%+65.92%+88.58% 23.32B
+3.88%+2.16%+11.78%+201.51% 19.89B
-1.59%-1.63%+61.04%+130.75% 16.91B
Average -1.48%-3.01%+30.93%+47.45% 32.02B
Weighted average by Cap. -1.36%-2.83%+30.42%+49.23%

Financials

2024 2025
Net sales 1.01B 31.44M 27.5M 25.36M 23.43M 44.45M 3B 45.2M 303M 119M 1.48B 118M 115M 5.08B 1.01B 31.32M 27.39M 25.27M 23.34M 44.28M 2.99B 45.03M 302M 119M 1.47B 118M 115M 5.06B
Net income -698M -21.76M -19.03M -17.55M -16.21M -30.76M -2.08B -31.28M -210M -82.37M -1.02B -81.7M -79.92M -3.51B -761M -23.7M -20.73M -19.12M -17.66M -33.51M -2.26B -34.07M -228M -89.71M -1.11B -88.97M -87.04M -3.83B
Net Debt -3.7B -115M -101M -92.92M -85.82M -163M -10.98B -166M -1.11B -436M -5.41B -432M -423M -18.6B -1.82B -56.7M -49.6M -45.75M -42.25M -80.18M -5.41B -81.52M -547M -215M -2.66B -213M -208M -9.16B
Logo EirGenix Inc.
EirGenix Inc is a Taiwan-based company primarily engaged in the development of antibody drugs and the manufacture of biopharmaceuticals. Its main businesses include the provision of Contract Development & Manufacturing Organization (CDMO) services, the construction of cell strain, the manufacture of clinical trial medicine, analytical science and protein identification, and PIC/S manufacturing plant to provide clinical trial drug production.
Employees
1,000
Date Price Change Volume
09/07/26 NT$48.25 -2.33% 721,110
08/07/26 NT$49.40 -2.56% 993,597
07/07/26 NT$50.70 -1.36% 1,502,393
06/07/26 NT$51.40 +3.42% 2,302,317
03/07/26 NT$49.70 +5.97% 1,611,002
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BB

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 6589 Stock